Oral etoposide for patients with advanced adenocarcinoma of the pancreas

被引：0
|
作者：
Eva Thomas
Pamela Dumas
Jaffer A. Ajani
机构：
[1] University of Texas M.D. Anderson Cancer Center,Departments of Gastrointestinal Oncology and Surgical Oncology
来源：
Investigational New Drugs | 1998年 / 16卷
关键词：
adenocarcinoma; pancreas; oral etoposide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose: Oral etoposide has been shown to be effective against some solid tumor types. This phase II study examined the efficacy of oral etoposide in patients with untreated advanced adenocarcinoma of the pancreas.
引用
收藏
页码：333 / 335
页数：2
相关论文
共 50 条
  • [41] Neoadjuvant Chemoradiotherapy improves the Survival in advanced Adenocarcinoma of the Pancreas
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (04): : 342 - 342
  • [42] COMBINATION CHEMOTHERAPY WITH ETOPOSIDE AND 5-FLUOROURACIL IN ADVANCED PANCREATIC ADENOCARCINOMA
    CHRISTIANSEN, NP
    KENNEDY, BJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (01): : 46 - 48
  • [43] Oral etoposide as first-line therapy in the treatment of patients with advanced classic Kaposi's sarcoma (CKS): a single-arm trial (oral etoposide in CKS)
    Tas, F.
    Sen, F.
    Keskin, S.
    Kilic, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 (06) : 789 - 792
  • [44] Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas
    Braghiroli, Maria Ignez
    de Celis Ferrari, Anezka C. R.
    Pfiffer, Tulio Eduardo
    Alex, Alexandra Kichfy
    Nebuloni, Daniela
    Carneiro, Allyne S.
    Caparelli, Fernanda
    Senna, Luiz
    Lobo, Juliana
    Hoff, Paulo Marcelo
    Riechelmann, Rachel P.
    ECANCERMEDICALSCIENCE, 2015, 9
  • [45] Phase II trial of inetforrnin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas
    Rubin De Celia Ferrari, Anezlca Carvalho
    Flesch Pfiffer, Tulio Eduardo
    Alex, Alexandra Khichfy
    Nebulonl, Danielle R.
    Carnelro, Allyne Q.
    Caparell, Fernanda Cunha
    Senna Leite, Luiz Antonio
    Freitas Meiro Braghiroli, Maria Ignez
    Lobo, Juliana
    Hoff, Paulo Marcelo
    Riechelmann, Rachel Pimenta
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma
    Paola Aita
    Isabelle Robieux
    Roberto Sorio
    Salvatore Tumolo
    Giuseppe Corona
    Renato Cannizzaro
    Anna Maria Colussi
    Mauro Boiocchi
    Giuseppe Toffoli
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 287 - 294
  • [47] Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma
    Aita, P
    Robieux, I
    Sorio, R
    Tumolo, S
    Corona, C
    Cannizzaro, R
    Colussi, AM
    Boiocchi, M
    Toffoli, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (04) : 287 - 294
  • [48] Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide
    deJong, RS
    Mulder, NH
    Uges, DRA
    Kaul, S
    Winograd, B
    Sleijfer, DT
    Groen, HJM
    Willemse, PHB
    vanderGraaf, WTA
    deVries, EGE
    BRITISH JOURNAL OF CANCER, 1997, 75 (11) : 1660 - 1666
  • [49] Randomized comparison of etoposide pharmacokinetics after oral etoposide phosphate and oral etoposide
    RS de Jong
    NH Mulder
    DRA Uges
    S Kaul
    B Winograd
    DTh Sleijfer
    HJM Groen
    PHB Willemse
    WTA van der Graaf
    EGE de Vries
    British Journal of Cancer, 1997, 75 : 1660 - 1666
  • [50] Oral etoposide for merkel cell carcinoma in patients previously treated with intravenous etoposide
    Fenig, E
    Brenner, B
    Njuguna, E
    Katz, A
    Schachter, J
    Sulkes, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (01): : 65 - 67
12345